Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Enhanced tumor development by butylated hydroxytoluene (BHT) in liver, lung and gastrointestinal tract

Conference ·
OSTI ID:5876771

Continuous feeding of 0.5% or 0.05% of butylated hydroxytoluene (BHT) enhances the development of spontaneously occurring liver tumors in C3H mice, but not in BALB/c mice. In mouse lung, the tumor-enhancing effects of BHT vary with the carcinogen used and in the gastrointestinal tract of mice and rats BHT enhances development of dimethylhydrazine-induced tumors but is without effect on tumors produced by methylnitrosourea. Strain differences, effect upon various carcinogens, paradoxical dose-responses and mechanisms of action remain major questions in the toxicology of BHT. 14 refs., 2 tabs.

Research Organization:
Oak Ridge National Lab., TN (USA)
DOE Contract Number:
AC05-84OR21400
OSTI ID:
5876771
Report Number(s):
CONF-8604155-1; ON: TI86009149
Country of Publication:
United States
Language:
English